First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the "menace" arrives in the new world

OXA-48 has emerged as a major carbapenemase associated with the Enterobacteriaceae in Europe, North Africa, and Asia. We report the first two clinical cases of OXA-48-type carbapenemase-producing Enterobacteriaceae in the United States from patients recently hospitalized in Saudi Arabia and India. E...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Journal of clinical microbiology Ročník 51; číslo 2; s. 680
Hlavní autori: Mathers, Amy J, Hazen, Kevin C, Carroll, Joanne, Yeh, Anthony J, Cox, Heather L, Bonomo, Robert A, Sifri, Costi D
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States 01.02.2013
Predmet:
Anti-Bacterial Agents - pharmacology
beta-Lactam Resistance - genetics
beta-Lactamases - biosynthesis
beta-Lactamases - genetics
Female
Humans
Klebsiella Infections - diagnosis
Klebsiella Infections - microbiology
Klebsiella pneumoniae - classification
Klebsiella pneumoniae - drug effects
Klebsiella pneumoniae - genetics
Microbial Sensitivity Tests
Middle Aged
Multilocus Sequence Typing
United States
United States
ISSN:1098-660X, 1098-660X
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:OXA-48 has emerged as a major carbapenemase associated with the Enterobacteriaceae in Europe, North Africa, and Asia. We report the first two clinical cases of OXA-48-type carbapenemase-producing Enterobacteriaceae in the United States from patients recently hospitalized in Saudi Arabia and India. Each is more carbapenem resistant than nearly all previously reported OXA-48-type-producing Enterobacteriaceae.
Bibliografia:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1098-660X
1098-660X
DOI:10.1128/JCM.02580-12